- Home
- Publications
- Publication Search
- Publication Details
Title
Inflammasome Proteins As Biomarkers of Multiple Sclerosis
Authors
Keywords
-
Journal
Frontiers in Neurology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-03-19
DOI
10.3389/fneur.2018.00135
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- Rescue therapy with alemtuzumab in multiple sclerosis post-natalizumab puerperium reactivation
- (2017) Jessica Frau et al. NEUROLOGICAL SCIENCES
- Induction of New Autoimmune Diseases After Alemtuzumab Therapy for Multiple Sclerosis
- (2017) Lawrence Steinman JAMA Neurology
- Myeloid cell transmigration across the CNS vasculature triggers IL-1β–driven neuroinflammation during autoimmune encephalomyelitis in mice
- (2016) Sébastien A. Lévesque et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Acidification changes affect the inflammasome in human nucleus pulposus cells
- (2016) Frank J. Brand et al. Journal of Inflammation-London
- A gene expression study denies the ability of 25 candidate biomarkers to predict the interferon-beta treatment response in multiple sclerosis patients
- (2016) Serena Martire et al. JOURNAL OF NEUROIMMUNOLOGY
- Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: results from a randomized, proof-of-concept study
- (2016) Eva Havrdová et al. JOURNAL OF NEUROLOGY
- An interferon-β-resistant and NLRP3 inflammasome–independent subtype of EAE with neuronal damage
- (2016) Makoto Inoue et al. NATURE NEUROSCIENCE
- Pharmacogenetics of multiple sclerosis
- (2016) Ekaterina Tsareva et al. Pharmacogenetics and Genomics
- Therapeutics targeting the inflammasome after central nervous system injury
- (2016) Juan Pablo de Rivero Vaccari et al. Translational Research
- Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
- (2015) J Kuhle et al. Multiple Sclerosis Journal
- Body fluid biomarkers for multiple sclerosis—the long road to clinical application
- (2015) Charlotte E. Teunissen et al. Nature Reviews Neurology
- Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis
- (2015) Yonghao Cao et al. Science Translational Medicine
- Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
- (2015) J Kuhle et al. Multiple Sclerosis Journal
- Revised diagnostic criteria of multiple sclerosis
- (2014) Ron Milo et al. AUTOIMMUNITY REVIEWS
- New Multiple Sclerosis Phenotypic Classification
- (2014) Fred D. Lublin EUROPEAN NEUROLOGY
- Pyroptotic Neuronal Cell Death Mediated by the AIM2 Inflammasome
- (2014) Stephanie E Adamczak et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- The Inflammasome Pyrin Contributes to Pertussis Toxin-Induced IL-1β Synthesis, Neutrophil Intravascular Crawling and Autoimmune Encephalomyelitis
- (2014) Aline Dumas et al. PLoS Pathogens
- Aquaporin-4 Antibodies (NMO-IgG) as a Serological Marker of Neuromyelitis Optica: A Critical Review of the Literature
- (2013) Sven Jarius et al. BRAIN PATHOLOGY
- MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials
- (2013) Maria Pia Sormani et al. LANCET NEUROLOGY
- The utility of cerebrospinal fluid analysis in patients with multiple sclerosis
- (2013) Martin Stangel et al. Nature Reviews Neurology
- Serum levels of interleukin (IL)-18, IL-23 and IL-17 in Chinese patients with multiple sclerosis
- (2012) Ying-Chun Chen et al. JOURNAL OF NEUROIMMUNOLOGY
- Translational biomarker discovery in clinical metabolomics: an introductory tutorial
- (2012) Jianguo Xia et al. Metabolomics
- Clinical relevance of differential lymphocyte recovery after alemtuzumab therapy for multiple sclerosis
- (2012) M. D. Cossburn et al. NEUROLOGY
- NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis
- (2012) M. Inoue et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interferon- Therapy Against EAE Is Effective Only When Development of the Disease Depends on the NLRP3 Inflammasome
- (2012) M. Inoue et al. Science Signaling
- Natalizumab (Tysabri)
- (2010) D.T. Selewski et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Cutting Edge: Critical Role for PYCARD/ASC in the Development of Experimental Autoimmune Encephalomyelitis
- (2010) P. J. Shaw et al. JOURNAL OF IMMUNOLOGY
- NLRP3 Plays a Critical Role in the Development of Experimental Autoimmune Encephalomyelitis by Mediating Th1 and Th17 Responses
- (2010) D. Gris et al. JOURNAL OF IMMUNOLOGY
- Therapeutic Neutralization of the NLRP1 Inflammasome Reduces the Innate Immune Response and Improves Histopathology after Traumatic Brain Injury
- (2009) Juan Pablo de Rivero Vaccari et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: The elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy
- (2009) Irena Dujmovic et al. JOURNAL OF NEUROIMMUNOLOGY
- IgG Antibodies against Measles, Rubella, and Varicella Zoster Virus Predict Conversion to Multiple Sclerosis in Clinically Isolated Syndrome
- (2009) Johannes Brettschneider et al. PLoS One
- Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
- (2008) Bruce D. Trapp et al. Annual Review of Neuroscience
- A Molecular Platform in Neurons Regulates Inflammation after Spinal Cord Injury
- (2008) J. P. de Rivero Vaccari et al. JOURNAL OF NEUROSCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation